ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease

Archive ouverte

Ledermann, J.A. | Matias-Guiu, X. | Amant, F. | Concin, N. | Davidson, B. | Fotopoulou, C. | González-Martin, A. | Gourley, C. | Leary, A. | Lorusso, D. | Banerjee, S. | Chiva, L. | Cibula, D. | Colombo, N. | Croce, S. | Eriksson, A.G. | Falandry, C. | Fischerova, D. | Harter, P. | Joly, F. | Lazaro, C. | Lok, C. | Mahner, S. | Marmé, F. | Marth, C. | Mccluggage, W.G. | Mcneish, I.A. | Morice, P. | Nicum, S. | Oaknin, A. | Pérez-Fidalgo, J.A. | Pignata, S. | Ramirez, P.T. | Ray-Coquard, I. | Romero, I. | Scambia, G. | Sehouli, J. | Shapira-Frommer, R. | Sundar, S. | Tan, D.S.P. | Taskiran, C. | van Driel, W.J. | Vergote, I. | Planchamp, F. | Sessa, C. | Fagotti, A.

Edité par CCSD ; Elsevier -

International audience. The European Society of Gynaecological Oncology, the European Society for Medical Oncology (ESMO) and the European Society of Pathology held a consensus conference (CC) on ovarian cancer on 15-16 June 2022 in Valencia, Spain. The CC panel included 44 experts in the management of ovarian cancer and pathology, an ESMO scientific advisor and a methodologist. The aim was to discuss new or contentious topics and develop recommendations to improve and harmonise the management of patients with ovarian cancer. Eighteen questions were identified for discussion under four main topics: (i) pathology and molecular biology, (ii) early-stage disease and pelvic mass in pregnancy, (iii) advanced stage (including older/frail patients) and (iv) recurrent disease. The panel was divided into four working groups (WGs) to each address questions relating to one of the four topics outlined above, based on their expertise. Relevant scientific literature was reviewed in advance. Recommendations were developed by the WGs and then presented to the entire panel for further discussion and amendment before voting. This manuscript focuses on the recommendation statements that reached a consensus, their voting results and a summary of evidence supporting each recommendation.

Consulter en ligne

Suggestions

Du même auteur

Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial

Archive ouverte | Harter, P. | CCSD

International audience. The use of first-line poly(ADP-ribose) polymerase (PARP) inhibitor maintenance therapy is increasing in advanced ovarian cancer. Understanding the efficacy of first subsequent therapy (FST) i...

2731 Impact of frailty on outcome of elderly patients treated with hormone therapy for advanced/recurrent endometrial cancer (EC)

Archive ouverte | Joly, F. | CCSD

International audience

SUCCOR cone study: conization before radical hysterectomy.

Archive ouverte | Chacon, E. | CCSD

International audience. Objective To evaluate disease-free survival of cervical conization prior to radical hysterectomy in patients with stage IB1 cervical cancer (International Federation of Gynecology and Obstetr...

Chargement des enrichissements...